147 related articles for article (PubMed ID: 31419467)
21. Disease-modifying effects of RHC80267 and JZL184 in a pilocarpine mouse model of temporal lobe epilepsy.
Ma L; Wang L; Yang F; Meng XD; Wu C; Ma H; Jiang W
CNS Neurosci Ther; 2014 Oct; 20(10):905-15. PubMed ID: 24989980
[TBL] [Abstract][Full Text] [Related]
22. Diurnal burden of spontaneous seizures in early epileptogenesis in the post-kainic acid rat model of epilepsy.
Mizuno S; Koneval Z; Zierath DK; Knox KM; White HS; Barker-Haliski M
Epilepsia Open; 2021 Jun; 6(2):431-436. PubMed ID: 34033257
[TBL] [Abstract][Full Text] [Related]
23. Anti-epileptogenic and Anti-convulsive Effects of Fingolimod in Experimental Temporal Lobe Epilepsy.
Pitsch J; Kuehn JC; Gnatkovsky V; Müller JA; van Loo KMJ; de Curtis M; Vatter H; Schoch S; Elger CE; Becker AJ
Mol Neurobiol; 2019 Mar; 56(3):1825-1840. PubMed ID: 29934763
[TBL] [Abstract][Full Text] [Related]
24. Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice.
Gröticke I; Hoffmann K; Löscher W
Exp Neurol; 2007 Oct; 207(2):329-49. PubMed ID: 17714705
[TBL] [Abstract][Full Text] [Related]
25. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
Glien M; Brandt C; Potschka H; Löscher W
Epilepsia; 2002 Apr; 43(4):350-7. PubMed ID: 11952764
[TBL] [Abstract][Full Text] [Related]
26. Protection against cognitive impairment and modification of epileptogenesis with curcumin in a post-status epilepticus model of temporal lobe epilepsy.
Jiang Z; Guo M; Shi C; Wang H; Yao L; Liu L; Xie C; Pu S; LaChaud G; Shen J; Zhu M; Mu L; Ge H; Long Y; Wang X; Song Y; Sun J; Hou X; Zarringhalam A; Park SH; Shi C; Shen H; Lin Z
Neuroscience; 2015 Dec; 310():362-71. PubMed ID: 26415768
[TBL] [Abstract][Full Text] [Related]
27. The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats.
Rattka M; Brandt C; Löscher W
Epilepsy Res; 2013 Feb; 103(2-3):135-52. PubMed ID: 23196211
[TBL] [Abstract][Full Text] [Related]
28. Scopolamine prevents aberrant mossy fiber sprouting and facilitates remission of epilepsy after brain injury.
Meller S; Käufer C; Gailus B; Brandt C; Löscher W
Neurobiol Dis; 2021 Oct; 158():105446. PubMed ID: 34280524
[TBL] [Abstract][Full Text] [Related]
29. Intracerebral delivery of the M2 polarizing cytokine interleukin 13 using mesenchymal stem cell implants in a model of temporal lobe epilepsy in mice.
Ali I; Aertgeerts S; Le Blon D; Bertoglio D; Hoornaert C; Ponsaerts P; Dedeurwaerdere S
Epilepsia; 2017 Jun; 58(6):1063-1072. PubMed ID: 28374921
[TBL] [Abstract][Full Text] [Related]
30. Rapid epileptogenesis in the mouse pilocarpine model: video-EEG, pharmacokinetic and histopathological characterization.
Mazzuferi M; Kumar G; Rospo C; Kaminski RM
Exp Neurol; 2012 Dec; 238(2):156-67. PubMed ID: 22960187
[TBL] [Abstract][Full Text] [Related]
31. A novel animal model of acquired human temporal lobe epilepsy based on the simultaneous administration of kainic acid and lorazepam.
Kienzler-Norwood F; Costard L; Sadangi C; Müller P; Neubert V; Bauer S; Rosenow F; Norwood BA
Epilepsia; 2017 Feb; 58(2):222-230. PubMed ID: 28157273
[TBL] [Abstract][Full Text] [Related]
32. Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat.
Goffin K; Nissinen J; Van Laere K; Pitkänen A
Exp Neurol; 2007 Jun; 205(2):501-5. PubMed ID: 17442304
[TBL] [Abstract][Full Text] [Related]
33. Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy.
Jimenez-Pacheco A; Diaz-Hernandez M; Arribas-Blázquez M; Sanz-Rodriguez A; Olivos-Oré LA; Artalejo AR; Alves M; Letavic M; Miras-Portugal MT; Conroy RM; Delanty N; Farrell MA; O'Brien DF; Bhattacharya A; Engel T; Henshall DC
J Neurosci; 2016 Jun; 36(22):5920-32. PubMed ID: 27251615
[TBL] [Abstract][Full Text] [Related]
34. Seizures in the intrahippocampal kainic acid epilepsy model: characterization using long-term video-EEG monitoring in the rat.
Raedt R; Van Dycke A; Van Melkebeke D; De Smedt T; Claeys P; Wyckhuys T; Vonck K; Wadman W; Boon P
Acta Neurol Scand; 2009 May; 119(5):293-303. PubMed ID: 19388152
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of T-Type calcium channels in mEC layer II stellate neurons reduces neuronal hyperexcitability associated with epilepsy.
Nigam A; Hargus NJ; Barker BS; Ottolini M; Hounshell JA; Bertram EH; Perez-Reyes E; Patel MK
Epilepsy Res; 2019 Aug; 154():132-138. PubMed ID: 31132598
[TBL] [Abstract][Full Text] [Related]
36. Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy.
Tchekalarova JD; Ivanova NM; Pechlivanova DM; Atanasova D; Lazarov N; Kortenska L; Mitreva R; Lozanov V; Stoynev A
Pharmacol Biochem Behav; 2014 Dec; 127():27-36. PubMed ID: 25456349
[TBL] [Abstract][Full Text] [Related]
37. Subchronic cerebrolysin treatment alleviates cognitive impairments and dendritic arborization alterations of granular neurons in the hippocampal dentate gyrus of rats with temporal lobe epilepsy.
Zamudio SR; Pichardo-Macías LA; Díaz-Villegas V; Flores-Navarrete IL; Guzmán-Velázquez S
Epilepsy Behav; 2019 Aug; 97():96-104. PubMed ID: 31207446
[TBL] [Abstract][Full Text] [Related]
38. Effects of the T-type calcium channel antagonist Z944 on paired associates learning and locomotor activity in rats treated with the NMDA receptor antagonist MK-801.
Roebuck AJ; Marks WN; Liu MC; Tahir NB; Zabder NK; Snutch TP; Howland JG
Psychopharmacology (Berl); 2018 Nov; 235(11):3339-3350. PubMed ID: 30251162
[TBL] [Abstract][Full Text] [Related]
39. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy.
Polascheck N; Bankstahl M; Löscher W
Exp Neurol; 2010 Jul; 224(1):219-33. PubMed ID: 20353773
[TBL] [Abstract][Full Text] [Related]
40. The T-type calcium channel antagonist, Z944, reduces spinal excitability and pain hypersensitivity.
Harding EK; Dedek A; Bonin RP; Salter MW; Snutch TP; Hildebrand ME
Br J Pharmacol; 2021 Sep; 178(17):3517-3532. PubMed ID: 33871884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
